These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 155294)

  • 41. A comparison of the bronchodilator activity of Sch 1000 and salbutamol.
    Ruffin RE; Fitzgerald JD; Rebuck AS
    J Allergy Clin Immunol; 1977 Feb; 59(2):136-41. PubMed ID: 137922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined salbutamol and ipratropium bromide by inhalation in the treatment of severe acute asthma.
    Beck R; Robertson C; Galdès-Sebaldt M; Levison H
    J Pediatr; 1985 Oct; 107(4):605-8. PubMed ID: 2931507
    [No Abstract]   [Full Text] [Related]  

  • 43. Nebulised ipratropium and salbutamol in asthma.
    Storr J; Lenney W
    Arch Dis Child; 1986 Jun; 61(6):602-3. PubMed ID: 2942116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Salbutamol but not ipratropium abolishes leukotriene D4-induced gas exchange abnormalities in asthma.
    Dahlén B; Gómez FP; Casas A; Howarth PH; Dahlén SE; Rodriguez-Roisin R
    Eur J Clin Pharmacol; 2012 Oct; 68(10):1375-83. PubMed ID: 22457014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A therapeutic comparison of ipratropium bromide and salbutamol in asthmatic patients.
    Bell R; Sahay JN; Barber PV; Chatterjee SS; Cox G
    Curr Med Res Opin; 1982; 8(4):242-6. PubMed ID: 6217949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Additive effects of isoproterenol-phenylephrine aerosol following ipratropium bromide on airway obstruction in older patients with intrinsic asthma and chronic bronchitis.
    Fujimura M; Azuma H; Uotani K; Mifune J; Tanaka T; Matsuda T
    Jpn J Med; 1986 May; 25(2):122-6. PubMed ID: 2943921
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma.
    Petrie GR; Palmer KN
    Br Med J; 1975 Feb; 1(5955):430-2. PubMed ID: 1090337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Response to aerosol salbutamol, SCH 1000, and placebo in cystic fibrosis.
    Kattan M; Mansell A; Levison H; Corey M; Krastins IR
    Thorax; 1980 Jul; 35(7):531-5. PubMed ID: 6449095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Value and limitations of salbutamol in the treatment of the obstructive syndrome. Comparative study with a synthetic atropine-like agent].
    Uffholtz H; Sadoul P; Lempereur L; Sentissi M
    Minerva Med; 1976 Mar; 67(15):917-21. PubMed ID: 131259
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis.
    van Schayck CP; Folgering H; Harbers H; Maas KL; van Weel C
    Thorax; 1991 May; 46(5):355-9. PubMed ID: 1829865
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atropine methonitrate and salbutamol in chronic airways obstruction: peak effect and duration of action.
    Starke ID; Parker RA; Turner-Warwick M
    Respiration; 1982; 43(1):51-6. PubMed ID: 7089390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The effect of inhaled salbutamol on pulmonary gas exchange in patients with chronic obstructive bronchopneumopathy].
    Clerbaux T; Henry P; Veriter C; Nullens W; Detry B; Cao ML; Raphael D; Frans A
    Rev Mal Respir; 1992; 9(2):171-7. PubMed ID: 1565829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of salbutamol on gas compression in cystic fibrosis and asthma.
    Desmond KJ; Demizio DL; Allen PD; MacDonald ND; Coates AL
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):673-7. PubMed ID: 8118635
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of sch 1000 inhalation on arterial blood gases in patients with reversible airway obstruction.
    Marcq M; Minette A
    Acta Tuberc Pneumol Belg; 1975; 66(4-5):429-33. PubMed ID: 131480
    [No Abstract]   [Full Text] [Related]  

  • 55. Inhaled beta-2 agonist salbutamol for the treatment of transient tachypnea of the newborn.
    Armangil D; Yurdakök M; Korkmaz A; Yiğit S; Tekinalp G
    J Pediatr; 2011 Sep; 159(3):398-403.e1. PubMed ID: 21481414
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of Atrovent in micturition function, double blind cross-over study.
    Molkenboer JF; Lardenoye JG
    Scand J Respir Dis Suppl; 1979; 103():154-8. PubMed ID: 155291
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of terbutaline and salbutamol aerosols.
    Hartnett BJ; Marlin GE
    Aust N Z J Med; 1977 Feb; 7(1):13-5. PubMed ID: 326244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relative bronchodilatory responsiveness attributable to sympathetic and parasympathetic activity in bronchial asthma.
    Jindal SK; Kaur SJ
    Respiration; 1989; 56(1-2):16-21. PubMed ID: 2532383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative efficacy of salbutamol, ipratropium, and cromoglycate in the prevention of bronchospasm induced by exercise and hyperosmolar challenges.
    Boulet LP; Turcotte H; Tennina S
    J Allergy Clin Immunol; 1989 May; 83(5):882-7. PubMed ID: 2523921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the effects of inhaled ipratropium bromide and salbutamol on the bronchoconstrictor response to hypocapnic hyperventilation in normal subjects.
    Jamison JP; Glover PJ; Wallace WF
    Thorax; 1987 Oct; 42(10):809-14. PubMed ID: 2962333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.